A Bayesian Reanalysis of the CULPRIT-SHOCK Trial

2024-9-12

Do we have our FACTTs straight about Cor Pulmonale in ARDS?

2024-9-12

Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?

2024-9-10

Embracing the Olympic Spirit: Pioneering Cardiac Care Insights from the 2024 European Society of Cardiology Scientific Meeting and More!

2024-9-6

<i>In perspective</i>: Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery (TIGHT-K) trial

2024-9-6

Answer: rapid neurological deterioration

2024-9-3

Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysis

2024-9-1

Epidemiology of Cardiogenic Shock Using the Shock Academic Research Consortium (SHARC) Consensus Definitions

2024-8-29

Long-term outcomes among out-of-hospital cardiac arrest survivors with reversible versus non-reversible causes

2024-8-29

Echo dynamics or PAC-dynamics? Should they be mutually exclusive?

2024-8-27

Question: rapid neurological deterioration

2024-8-27

Not Opposite, but Complementary! When Palliative Care Empowers Intensive Care

2024-8-20

Sudden cardiac death after early-onset myocardial infarction. A multicentre longitudinal cohort study with 20 years’ follow-up

2024-8-6

Answer: Pericardial double trouble

2024-8-1

Question: Pericardial double trouble

2024-7-25

Is there a role for pre-hospital administration of potent antiplatelet therapy in STEMI?

2024-7-24

Clinical decision support using machine learning and cardiac troponin for the diagnosis of myocardial infarction

2024-7-19

Relevance of Age and Hypertension for Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest – A BOX-trial sub study

2024-7-19

Revolutionizing Cardiac Care: Insights e into Shock Prognosis, Myocardial Infarction Management, and Platelet Inhibition

2024-7-18

In response to “Killip scale reclassification according to lung ultrasound: Killip pLUS”, by Carreras-Mora et al

2024-7-18

Comprehensive non-invasive Hemodynamic Assessment in Acute Decompensated Heart Failure-Related Cardiogenic Shock. A step towards echodynamics

2024-7-16

Science Pulse: Management of cardiogenic shock and trial design - time for a paradigm shift! Insights from the 3CT Meeting

2024-7-10

Editor's Chronicles: Redefining Pathways in Acute Cardiac Care

2024-7-3

Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T

2024-7-2

Characteristics and Outcome in Cardiogenic Shock according to Vascular Access Site for PCI

2024-6-26

High-sensitivity cardiac troponin and uncertainties in the diagnosis, treatment and communication of risk in acute myocardial infarction

2024-6-24

Enhancing Robustness in Acute Cardiovascular Observational Studies: Evaluating Covariate Adjustment

2024-6-12

Prehospital Tirofiban Increases the Rate of Disrupted Myocardial Infarction in Patients with ST-Segment Elevation Myocardial Infarction: Insights From the On-TIME 2 Trial

2024-6-7

Cardiovascular medications, high-sensitivity cardiac troponin T concentrations, and long-term outcome in non-ST segment elevation acute coronary syndrome

2024-6-6

Killip scale reclassification according to lung ultrasound: Killip pLUS

2024-6-4

Ten-year prognosis of acute atrial fibrillation in ST-elevation myocardial infarction: recurrence and risk stroke

2024-6-3

Answer: Multiple free-floating cardiac masses in a young woman with pulmonary embolism

2024-6-1

Targeted Proteomic Profiling of Cardiogenic Shock in the Cardiac Intensive Care Unit

2024-5-30

Spontaneous coronary artery dissection – We are the patients

2024-5-29

Validation of the CREST model &amp; Comparison with SCAI Shock Classification for Prediction of Circulatory Death in Resuscitated Out of Hospital Cardiac Arrest

2024-5-28

Question: Multiple free-floating cardiac masses in a young woman with pulmonary embolism

2024-5-27

Residual ischemia in acute myocardial infarction complicated by cardiogenic shock undergoing VA-ECMO: does complete revascularization hold the key?

2024-5-20

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention therapies 12 months after acute myocardial infarction

2024-5-20

Predicting the unpredictable: a novel application of artificial intelligence in the cardiac intensive care unit

2024-5-17

Clinical decision support using machine learning and natriuretic peptides for the diagnosis of acute heart failure

2024-5-16

Portal Vein Doppler tracks volume status in patients with severe tricuspid regurgitation: A Proof-of-Concept Study

2024-5-12

Acute cardiovascular and intensive care chronicles: Crossing New Frontiers in Advanced Cardiovascular Therapeutics

2024-5-3

Correction to: Serum cholinesterase as a prognostic biomarker for acute heart failure

2024-5-3

Clinical Significance of Residual Ischemia in Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing VA-ECMO

2024-5-3

Answer: Surviving the storm: ventricular fibrillation in the left ventricle assist device era

2024-5-2

Answer: Acute lateral ST elevation in a patient with abdominal pain

2024-5-2

Unveiling new horizons: revolutionary insights into acute myocarditis and optimal mechanical circulatory support timing

2024-5-1

Self-management for physicians: an interview with Professor Alexander Ghanem

2024-5-1

Antithrombotic management during percutaneous mechanical circulatory support – defining the status quo, before agreeing quo vadis

2024-4-30

Non-invasive imaging in acute decompensated heart failure with preserved ejection fraction

2024-4-25